Why use SAS in pharmacy

20 companies from Saxony-Anhalt at the CPhI 2018 in Madrid

Saxony-Anhalt's pharmaceutical industry remains on course for growth and internationalization

The gross value added of the healthcare industry in Saxony-Anhalt increased by 3.5 percent in 2017 to 6.7 billion euros. This means that 12.3 percent of the macroeconomic gross value added was generated by the 154.5 thousand employees in the health industry. The fifty companies in the pharmaceutical and biotech industry in Saxony-Anhalt with their more than 5,000 employees have turned over around 1.37 billion euros of this in this period. An established pharmaceutical and vaccine industry, the birthplace of homeopathy, a long tradition as a chemical location, a close hand-in-hand of research companies, manufacturing locations and higher education along the entire value chain, as well as powerful clusters and networks in the state: It is this mixture that makes Saxony- What makes Anhalt so successful as a location for the pharmaceutical industry.

As part of a common Country presentation in hall H1 at booth 1G82 presents the IMG - Investment and Marketing Company Saxony-Anhalt mbH together with the Heppe Medical Chitosan GmbH, World market leader for high quality chitosan, and the Wessling GmbH, one of the leading analysis, testing and consulting companies in Europe, den Life science location Saxony-Anhalt. The focus is on the outstanding interdisciplinary working conditions and research activities in the country. “Saxony-Anhalt remains an absolutely interesting location for the pharmaceutical industry as well as for the high-tech suppliers of fine chemicals. The expansion investments, for example of the Serumwerk in Bernburg, the Pharma Wernigerode GmbH, the IDT Biologika GmbH, the Merz Pharma GmbH in Dessau or the Oncotec Pharma Production GmbH but also the steady growth of industry giants such as Bayer in Bitterfeld or the Sandoz subsidiary Salutas Pharma in Barleben are convincing evidence that the locations are internationally competitive - despite the high development costs that the industry is struggling with internationally, ”explains Thomas Einsfelder, Managing Director of IMG - Investment and Marketing Company Saxony-Anhalt mbH. "At the CPhI in Madrid we want to invite other partners to benefit from the location factors in Saxony-Anhalt together with the companies and research institutions," said Einsfelder.

Saxony-Anhalt offers the best conditions for pharmaceutical companies. An established pharmaceutical and vaccine industry, the birthplace of homeopathy, a long tradition as a chemical location, a close hand-in-hand of research companies, manufacturing locations and higher education along the entire value chain, as well as powerful clusters and networks in the state: It is this mixture that makes Saxony- What makes Anhalt so successful as a location for the pharmaceutical industry. Three aspects are particularly in focus in Madrid.

Due to the long tradition as a chemical location, Saxony-Anhalt has become an important one Competence center in the field of fine chemicals within Germany established. Thanks to the companies and research institutes at the site, highly specialized know-how is concentrated at the site. With 4chiral there is also a unique network of manufacturers of specialty and fine chemicals as well as scientific institutions

Pharmaceutical companies find good settlement and growth conditions in Saxony-Anhalt thanks to the close cooperation between business and science. Specialized industrial parks such as the BiopharmaPark Dessau offer companies in the industry services that help them concentrate on their core business. Pharmaceutical companies are located here that not only benefit from the special infrastructure and service network at the location. The close proximity to one another results in synergies from pharmaceutical production and packaging to research and development. The 120 hectare state-of-the-art site - 90 kilometers south of Berlin, 60 kilometers north of Leipzig - has developed into a global center for pharmaceutical and biotechnology. The companies based here have a high level of expertise in pharmaceutical production and packaging, in innovative vaccine technology, in quality control and compliance as well as in research and development. In addition to the synergies that they use here, the companies benefit from a functioning production infrastructure

A specialized infrastructure and funding structure in Saxony-Anhalt supports start-ups in the pharmaceutical sector, such as am Vineyard campusTo network science and business in the second largest technology park in East Germany, to offer companies optimal starting conditions, that is the successful concept of the technology park Weinberg Campus in Halle (Saale). Today it is the largest innovation location for the life sciences and material sciences industry in central Germany. More than 70 companies and institutes, facilities and service providers from the fields of biotechnology, biomedicine, environmental and medical technology as well as nanotechnology and IT are located here. Companies and the natural science institutes of the Martin Luther University Halle-Wittenberg, the research institutes of the Max Planck and Fraunhofer societies as well as the Leibniz and Helmholtz communities work in an almost unique spatial proximity on one campus. In addition to 5,500 employees, there are 7,500 students on campus.

Information on the locations and exhibitors from Saxony-Anhalt can be found here: www.investieren-in-sachsen-anhalt.de/cphi-2018

Further exhibitors from Saxony-Anhalt at CPhI Worldwide 2018:

 

Background: CPhI Worldwide Madrid 2018

Established in 1990 as an international chemical and pharmaceutical trade fair, the CPhI is now one of the largest pharmaceutical trade fairs in the world. It is a forum for producers, suppliers and buyers in the chemical and pharmaceutical industry. The spectrum includes all active pharmaceutical ingredients, outsourcing, device and bio solutions. CPhI Worldwide in Madrid expects more than 45,000 visitors from October 9th to 11th. 2,500 exhibitors from 153 countries meet at the event to network and take advantage of more than 150 free industry seminars. New in Madrid is bioLIVE - a specialist event with a focus on the growing sector of the biopharmaceutical industry.